CXCL13 and neoplasm: Zhang et al. found that the tumor microenvironment in response to patients was enriched with two groups of T cells with high expression of CXCL13 (CD8-CXCL13 and CD4-CXCL13) [43], and also highly expressed T cytotoxicity and exhaustion-related genes [44].